{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:17:06Z","timestamp":1762507026301,"version":"3.37.3"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/501100004836","name":"Danish Council for Independent Research","doi-asserted-by":"publisher","award":["DFF \u2013 4004-00225"],"award-info":[{"award-number":["DFF \u2013 4004-00225"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004836","name":"Danish Council for Independent Research","doi-asserted-by":"publisher","award":["DFF \u2013 4004-00225"],"award-info":[{"award-number":["DFF \u2013 4004-00225"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,2,1]]},"DOI":"10.1093\/europace\/euw408","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T15:54:32Z","timestamp":1487951672000},"page":"301-307","source":"Crossref","is-referenced-by-count":8,"title":["The use of guideline recommended beta-blocker therapy in primary prevention implantable cardioverter defibrillator patients: insight from Danish nationwide registers"],"prefix":"10.1093","volume":"20","author":[{"given":"Anne-Christine","family":"Ruwald","sequence":"first","affiliation":[{"name":"Department of Cardiology, Herlev-Gentofte University Hospitals, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar Hilmar","family":"Gislason","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Herlev-Gentofte University Hospitals, Copenhagen, Denmark"},{"name":"National Institute of Public Health, Copenhagen, Denmark"},{"name":"Department of Cardiology, University of Southern Denmark, Odense, Denmark"},{"name":"The Danish Heart Foundation"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Vinther","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Herlev-Gentofte University Hospitals, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Brock","family":"Johansen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Odense University Hospital, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens Cosedis","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen H\u00f8gh","family":"Petersen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Torp-Pedersen","sequence":"additional","affiliation":[{"name":"Department of Clinical Epidemiology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"Riahi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"J\u00f8ns","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"key\n\t\t\t\t20180328152118_euw408-B1","first-page":"1601","article-title":"ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC)endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"17","author":"Priori","year":"2015","journal-title":"Europace"},{"key":"key\n\t\t\t\t20180328152118_euw408-B2","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t20180328152118_euw408-B3","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(99)04440-2","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328152118_euw408-B4","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328152118_euw408-B5","doi-asserted-by":"crossref","first-page":"26L","DOI":"10.1016\/S0002-9149(97)00846-1","article-title":"Mechanism of action of beta-blocking agents in heart failure","volume":"80","author":"Bristow","year":"1997","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180328152118_euw408-B6","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1161\/01.CIR.94.11.2817","article-title":"Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart","volume":"94","author":"Gilbert","year":"1996","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328152118_euw408-B7","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328152118_euw408-B8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180328152118_euw408-B9","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.jacc.2015.12.046","article-title":"Use of guideline-directed medications for heart failure before cardioverter-defibrillator implantation","volume":"67","author":"Roth","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328152118_euw408-B10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ahj.2012.06.009","article-title":"The natural history of new-onset heart failure with a severely depressed left ventricular ejection fraction: implications for timing of implantable cardioverter-defibrillator implantation","volume":"164","author":"Teeter","year":"2012","journal-title":"Am Heart J"},{"key":"key\n\t\t\t\t20180328152118_euw408-B11","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2011.10.033","article-title":"How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with \u201cSCD-HeFT criteria?\u201d","volume":"109","author":"Zecchin","year":"2012","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180328152118_euw408-B12","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/eurjhf\/hft134","article-title":"Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12,440 patients of the ESC Heart Failure Long-Term Registry","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20180328152118_euw408-B13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/CIRCHEARTFAILURE.114.001701","article-title":"Carvedilol compared with Metoprolol Succinate in the treatment and prognosis of patients with stable chronic heart failure: Carvedilol or Metoprolol Evaluation Study","volume":"8","author":"Frohlich","year":"2015","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180328152118_euw408-B14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/ejhf.81","article-title":"Comparison of the clinical outcome of different beta-blockers in heart failure patients: a retrospective nationwide cohort study","volume":"16","author":"Bolling","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"key\n\t\t\t\t20180328152118_euw408-B15","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jamainternmed.2014.3258","article-title":"Association of treatment with carvedilol vs metoprolol succinate and mortality in patients with heart failure","volume":"174","author":"Pasternak","year":"2014","journal-title":"JAMA Intern Med"},{"key":"key\n\t\t\t\t20180328152118_euw408-B16","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1161\/CIRCHEARTFAILURE.109.912683","article-title":"Comparison of medical therapy dosing in outpatients cared for in cardiology practices with heart failure and reduced ejection fraction with and without device therapy: report from IMPROVE HF","volume":"3","author":"Heywood","year":"2010","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180328152118_euw408-B17","article-title":"Association between remote implantable cardioverter defibrillator monitoring and beta-blocker utilization: an analysis from the EFFECT study","author":"D\u2019Onofrio","year":"2015","journal-title":"J Telemed Telecare"},{"key":"key\n\t\t\t\t20180328152118_euw408-B18","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/j.amjcard.2008.07.045","article-title":"Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure","volume":"102","author":"Fonarow","year":"2008","journal-title":"Am J Cardiol"},{"key":"key\n\t\t\t\t20180328152118_euw408-B19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.jacc.2013.01.020","article-title":"Effect of Metoprolol Versus Carvedilol on Outcomes in MADIT-CRT","volume":"61","author":"Ruwald","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328152118_euw408-B20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2165\/00129784-200101010-00001","article-title":"Beta-blockade in heart failure: selective versus nonselective agents","volume":"1","author":"Metra","year":"2001","journal-title":"Am J Cardiovasc Drugs"}],"container-title":["EP Europace"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/europace\/article-pdf\/20\/2\/301\/23794723\/euw408.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T17:52:28Z","timestamp":1522259548000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/20\/2\/301\/3037964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,20]]},"published-print":{"date-parts":[[2018,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euw408","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"type":"print","value":"1099-5129"},{"type":"electronic","value":"1532-2092"}],"subject":[],"published-other":{"date-parts":[[2018,2]]},"published":{"date-parts":[[2017,2,20]]}}}